biotech recruitment agency and biotechnology headhunters
your next biotech hire, in good hands.
We combine our data, our sector experts and our AI algorithms to identify the headhunter most relevant to your role, from researcher to CFO.
- no setup fees, pay on hire
- guaranteed replacement
they hire with muzzo in biotech
how do you hire in biotech through a recruitment agency?
Muzzo hires for biotech start-ups and scale-ups : researchers, R&D project leads, bioinformaticians, CMC officers, business developers and CFOs. Each role goes to headhunters who know biotech funding cycles. Fee of 5 to 30%, paid on hire. Leaves within 3 months: search restarted free.
how it works
you only pay if you hire
01
you describe the role
Using the form above: the role, your company, your project. The rest is scoped in your first conversation with the Muzzo team.
02
the right headhunters get started
Those who have already recruited for this field, from research to funding.
03
you meet the profiles
Already approached and qualified. You choose who you meet.
04
you hire, then you pay
Not before. If your new hire leaves within 3 months, we restart the search at no cost.
they hired with muzzo
Muzzo's strength is the diversity of its recruiters: there is always someone listening to our needs.
With Muzzo, I get the reactivity of a marketplace and the quality of a search firm.
let's talk about your role
Antoine and the Muzzo team help you scope your role and choose the right headhunters. Describe your role in the form: we'll call you back to discuss it.
Antoine GigomasCEO and co-founder of Muzzo
one last question?
You set the fee for each role, between 5 and 30%, and you only pay it on hire. No deposit, no fixed fees. A junior researcher and a listed biotech CFO don't take the same effort : the fee follows how rare the profile is, and the Muzzo team helps you set it.
You have a double guarantee. If your new hire leaves within 3 months, we restart the search at no cost. If we find no replacement within 4 months, we refund 50% of the fees. On average, 94% of Muzzo hires are still in post after 3 months.
our biotech headhunters are ready to start
A hire signed in under 26 days, paid only on hire.
the reality
in biotech, the profile follows the company stage
research attracts few unsolicited applications
A good researcher or bioinformatician is followed by few agencies. You have to approach them directly, in their lab or previous start-up.
a role changes with every funding round
After funding, a biotech company often shifts from research to manufacturing. The profile you need to hire is no longer the same.
biotech finance is not classic finance
A biotech CFO manages cash between funding rounds or licensing revenue, not a classic recurring revenue stream.
the roles
the biotech profiles our headhunters go after for you
From research to funding, each role goes to a headhunter who knows biotech cycles.
researcher and R&D project lead
They run a research program through proof of concept, in connection with scientific teams and academic partners.
bioinformatician
They analyze sequencing or screening data and build tools that speed up research.
CMC officer
They prepare chemistry, manufacturing and controls data needed for the regulatory dossier of a drug candidate.
business developer and licensing officer
They negotiate licensing deals and partnerships that fund biotech asset development.
CFO of funded or listed company
They manage cash between funding rounds, investor reporting and, where applicable, listed company obligations.
the method
a biotech headhunter, not an agency that does everything
Research, manufacturing or funding: your company stage changes the profile needed. The method starts from that stage.
we place the role in the company cycle
Research, proof of concept, manufacturing or post-funding: the brief sets out the stage, program and scientific or financial stakeholders.
one headhunter per field
From more than 2,500 selected headhunters, your role goes to those who place the most people in that field: research, bioinformatics, business development or finance.
publications and deals checked before the interview
The headhunter asks which programs, publications or licensing deals the profile led, then cross-checks via reference.
the figures
biotech hiring in figures
112,107employees
private-sector employees in scientific research and development (NA88 division 72, which includes biotech), end June 20261
41.8%
of 1,100 hiring plans for researchers (outside industry and higher education) rated hard to fill in 20262
4,610plans
hiring plans for study, research and development technicians in 2026, of which 46.0% are hard to fill3
- Urssaf, private-sector salaries and payroll by sector (NA88) (opens a new window), 2026 data
- France Travail, BMO 2026 survey, researchers outside industry and higher education (opens a new window), 2026 data
- France Travail, BMO 2026 survey, study, research and development technicians (opens a new window), 2026 data
hiring in biotech: what you need to know
A biotech recruitment agency finds profiles for biotech start-ups and scale-ups, in health, agro or industrial biotech : researchers, R&D project leads, bioinformaticians, CMC officers, business developers and CFOs. GMP production at large pharma labs has its own pharma page, and medical devices have their medtech page.
With Muzzo, your role is not posted as just another job ad. It goes to headhunters who place the most people in that exact field. The one who places researchers is not the one who places a listed biotech CFO.
At research stage, you need researchers, R&D project leads and bioinformaticians who run a program through proof of concept. At manufacturing stage, CMC officers who prepare manufacturing dossier data.
After funding, needs shift: business developers and licensing officers to secure partnerships, CFOs to manage cash and investor reporting. The brief must say what stage your company is at.
A researcher or bioinformatician is judged on the programs they led and the publications or tools they produced, not just a job title. The headhunter verifies these elements and the real level of autonomy on a program.
They also tell you what the profile will need to learn with you, for example a new therapeutic area or a new technology platform, so onboarding is planned from the offer.
how do you hire a CFO for a funded biotech company?
Biotech finance is managed between funding rounds, sometimes with no recurring revenue, or with irregular licensing income. A CFO from a classic sector needs to learn these cycles before managing cash.
The headhunter verifies the profile's experience with these cycles: how many funding rounds managed, what investor reporting, what experience with a listed company if applicable.
France Travail's 2026 BMO survey says 41.8% of 1,100 hiring plans for researchers (outside industry and higher education) are hard to fill, versus 43.8% across all jobs. Study, research and development technicians count 4,610 hiring plans, of which 46.0% are hard to fill.
These figures count all levels, not just managers. They say one thing simply: for these roles, a job ad is not enough. Headhunters approach profiles already in post, in academic labs and biotech companies.
A good biotech profile is in post, often in the middle of a research program or funding cycle. Headhunters approach them directly in academic labs, start-ups and listed companies. They verify the programs and deals actually led and introduce few profiles, all qualified.
Your searches stay confidential: funding in prep, a scientific pivot or the departure of an R&D director are never announced. On an urgent role, several headhunters can search together, each in their own network.
your questions about hiring in biotech
Yes, both. Our headhunters hire researchers and bioinformaticians on one side, business developers and CFOs on the other. Each role goes to the headhunter who knows that field : you don't look for a researcher in the same networks as a listed biotech CFO.
According to Urssaf, the scientific research and development sector, which includes biotech among other disciplines, employed 112,107 private-sector employees end June 2026, all levels.
Yes. France Travail's 2026 BMO survey says 41.8% of 1,100 hiring plans for researchers outside industry and higher education are hard to fill, versus 43.8% across all jobs. For this role, headhunters approach profiles already in post rather than wait for job ad replies.
Yes, on our pharma and medtech pages, dedicated to large pharma labs and CDMO manufacturing, and medical device makers. This page covers biotech start-ups and scale-ups. Either way, the role goes to the headhunter who knows the sector.
by Antoine Gigomas, CEO and co-founder of Muzzo ·
